-- 
Lilly, Amylin’s Byetta Approved for New Use by U.S. Regulators

-- B y   V i v e k   S h a n k a r
-- 
2011-10-19T22:16:52Z

-- http://www.bloomberg.com/news/2011-10-19/lilly-amylin-s-byetta-approved-for-new-use-by-u-s-regulators.html
Eli Lilly & Co. (LLY)  and Amylin
Pharmaceutical Inc.’s Byetta diabetes drug was approved by the
U.S. Food and Drug Administration for a new use -- as an add-on
treatment to insulin glargine for some type 2 diabetics.  To contact the editor responsible for this story:
Vivek Shankar at 
 vshankar3@bloomberg.net  